|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Price,financial quality,and capital flows in insurance markets显示文摘 | Cummins D J Danzon P N | 1997 | Journal of Financial Inter-mediation1997，6，： | 1 |
| 2 | Price, financial quality and capital flows in insurance markets 显示文摘 | Cummins D P Danzon | 1997 | Journal of Financial Intermediation1997，6，： | 1 |
| 3 | The impact of price regulation on the launch delay of new drugs: evolution from twenty-five major markets in the 1990s显示文摘 | Danzon P M Wang Y Wang L | 2005 | Health Economies2005，14，3： | 1 |
| 4 | Reference pricing:efficient insurance design or monopsony free riding?显示文摘 | Danzon P | 1998 | Pharma Pricing Review1998，3，7： | 1 |
| 5 | Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand显示文摘 | Danzon P M Ketcham J D | 2004 | Front Health Policy Res2004，，7： | 1 |
| 6 | Cross-national price differences for pharmaceuticals: how large, and why? 显示文摘 | Danzon P M Chao L W | 2000 | Journal of health economics2000，19，2： | 1 |
| 7 | International price comparisons for pharmaceuticals 显示文摘 | Danzon P M Kim J D | 1998 | Pharmaeoeeonomies1998，14，1： | 1 |
| 8 | Tort reform and the role of govermnent in private insurance markets 显示文摘 | DANZON P M | 1984 | Legal Studies1984，13，3： | 1 |
| 9 | Productivity in pharmaceutical - biotechnology R&D : the role of experience and alliances 显示文摘 | Danzon P M Nicholson S Pereira N S | 2005 | Journal of Health Economics2005，24，2： | 1 |
| 10 | Making sense of drug prices显示文摘 | Danzon P | 2000 | Regulation2000，23，1： | 1 |
| 11 | Price, Financial quality, and capital flows in insurance markets 显示文摘 | Cummins J D Danzon P M | 1997 | Jounal of Insurance Inermediation1997，6，： | 1 |
| 12 | Liability for Medical Malpractice显示文摘 | Danzon P M | 1991 | JEP1991，5，3： | 1 |
| 13 | Price,Financial quality,and capital flows in insurance markets显示文摘 | Danzon P M | 1997 | Jurnal of Insurance Intermediation1997，6，： | 1 |
| 14 | Price, financial quality and capital flows in insurance markets 显示文摘 | Cummins D Danzon P | 1997 | Journal of Financial Intermediation1997，6，： | 1 |
| 15 | Productivity in pharmaceutical- biotechnology R&D: the role of experience and alliances 显示文摘 | DANZON P M NICHOLSON S PEREIBA N S | 2005 | Journal of Health Economics2005，24，2： | 1 |
| 16 | International price comparisons for pharmaceuticals显示文摘 | Danzon P M Kim J D | 1998 | Pharmacoeconomics1998，14，11： | 1 |
| 17 | Hidden Overhead Costs:Is Canada's System Re ally Less Expensive?显示文摘 | Danzon P | 1992 | Health Affairs1992，11，1： | 1 |
| 18 | The impact of price regulation on the launch delay of new drugs? Evidence from twenty-five major markets in the 1990s 显示文摘 | Danzon P M Wang R L Wang L | 2005 | Health Eco- nomics2005，14，3： | 1 |
| 19 | Hidden Overhead Costs:Is Canada's System Re ally Less Expensive?显示文摘 | Danzon P | 1992 | Health1992，1992，1： | 1 |
| 20 | Tort reform and the role of government in private insurance markets显示文摘 | DANZON P M | 1984 | Legal Studies1984，13，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员